ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,374Medicare Part D Prescriptions Filled, Including Refills

Rank: 1538 out of 5176

$455K Total Retail Price of All Prescriptions

Rank: 1377 out of 5176

471 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 5,823 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 386 356 1 1
AMLODIPINE BESYLATE 309 292 2 2
LEVOTHYROXINE SODIUM 160 157 3 4
ZOLPIDEM TARTRATE 153 152 4 17
CRESTOR 127 123 5 15
RAMIPRIL 113 106 6 50
SERTRALINE HCL 113 113 6 30
SYNTHROID 109 95 8 33
METHYLPREDNISOLONE 108 88 9 218
AMOXICILLIN 107 90 10 163
LISINOPRIL 107 102 10 5
ATORVASTATIN CALCIUM 100 100 12 9
FUROSEMIDE 99 95 13 8
METOPROLOL TARTRATE 99 92 13 6
METOPROLOL SUCCINATE 91 90 15 11
TRAMADOL HCL 87 69 16 40
ATENOLOL 87 81 16 12
LOSARTAN POTASSIUM 86 76 18 14
WARFARIN SODIUM 85 79 19 13
OMEPRAZOLE 81 68 20 3
CARVEDILOL 79 75 21 24
METFORMIN HCL ER 76 73 22 57
LOSARTAN-HYDROCHLOROTHIAZIDE 76 53 22 35
GLIPIZIDE XL 75 75 24 83
PROCTOZONE-HC 68 67 25 171
DIOVAN HCT 67 62 26 39
TRIAMTERENE-HCTZ 67 63 26 86
CLOPIDOGREL 67 60 26 26
DONEPEZIL HCL 66 66 29 28
DIOVAN 66 63 29 19
DIGOXIN 65 62 31 56
HYDROCHLOROTHIAZIDE 65 64 31 10
ENALAPRIL MALEATE 56 56 33 22
PANTOPRAZOLE SODIUM 54 48 34 61
METFORMIN HCL 53 48 35 7
PRAVASTATIN SODIUM 53 44 35 23
LEVOFLOXACIN 52 47 37 109
FLUTICASONE PROPIONATE 50 48 38 38
PLAVIX 50 48 38 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.